BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 33946479)

  • 21. Excess body weight is an independent risk factor for severe forms of COVID-19.
    Pietri L; Giorgi R; Bégu A; Lojou M; Koubi M; Cauchois R; Grangeot R; Dubois N; Kaplanski G; Valéro R; Béliard S
    Metabolism; 2021 Apr; 117():154703. PubMed ID: 33421506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
    Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
    Front Immunol; 2021; 12():648004. PubMed ID: 33767713
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
    Danlos FX; Grajeda-Iglesias C; Durand S; Sauvat A; Roumier M; Cantin D; Colomba E; Rohmer J; Pommeret F; Baciarello G; Willekens C; Vasse M; Griscelli F; Fahrner JE; Goubet AG; Dubuisson A; Derosa L; Nirmalathasan N; Bredel D; Mouraud S; Pradon C; Stoclin A; Rozenberg F; Duchemin J; Jourdi G; Ellouze S; Levavasseur F; Albigès L; Soria JC; Barlesi F; Solary E; André F; Pène F; Ackerman F; Mouthon L; Zitvogel L; Marabelle A; Michot JM; Fontenay M; Kroemer G
    Cell Death Dis; 2021 Mar; 12(3):258. PubMed ID: 33707411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Severity and Intrahospital Mortality in COVID-19: The Place and Role of Oxidative Stress.
    Cekerevac I; Turnic TN; Draginic N; Andjic M; Zivkovic V; Simovic S; Susa R; Novkovic L; Mijailovic Z; Andjelkovic M; Vukicevic V; Vulovic T; Jakovljevic V
    Oxid Med Cell Longev; 2021; 2021():6615787. PubMed ID: 33854695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection.
    Lopez-Castaneda S; García-Larragoiti N; Cano-Mendez A; Blancas-Ayala K; Damian-Vázquez G; Perez-Medina AI; Chora-Hernández LD; Arean-Martínez C; Viveros-Sandoval ME
    Clin Appl Thromb Hemost; 2021; 27():1076029621999099. PubMed ID: 33835872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites.
    Alzahrani FA; Shait Mohammed MR; Alkarim S; Azhar EI; El-Magd MA; Hawsawi Y; Abdulaal WH; Yusuf A; Alhatmi A; Albiheyri R; Fakhurji B; Kurdi B; Madani TA; Alguridi H; Alosaimi RS; Khan MI
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution.
    Ravichandran S; Lee Y; Grubbs G; Coyle EM; Klenow L; Akasaka O; Koga M; Adachi E; Saito M; Nakachi I; Ogura T; Baba R; Ito M; Kiso M; Yasuhara A; Yamada S; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Imai M; Yamayoshi S; Yotsuyanagi H; Kawaoka Y; Khurana S
    Sci Adv; 2021 Mar; 7(10):. PubMed ID: 33674317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations.
    Cornillet M; Strunz B; Rooyackers O; Ponzetta A; Chen P; Muvva JR; Akber M; Buggert M; Chambers BJ; Dzidic M; Filipovic I; Gorin JB; Gredmark-Russ S; Hertwig L; Klingström J; Kokkinou E; Kvedaraite E; Lourda M; Mjösberg J; Maucourant C; Norrby-Teglund A; Parrot T; Perez-Potti A; Rivera-Ballesteros O; Sandberg JK; Sandberg JT; Sekine T; Svensson M; Varnaite R; ; Eriksson LI; Aleman S; Strålin K; Ljunggren HG; Björkström NK
    Eur J Immunol; 2022 Mar; 52(3):503-510. PubMed ID: 34837225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic signatures of acute respiratory distress syndrome: COVID versus non-COVID.
    Ji X; Ji HL
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L596-L603. PubMed ID: 38469648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage.
    Chen YM; Zheng Y; Yu Y; Wang Y; Huang Q; Qian F; Sun L; Song ZG; Chen Z; Feng J; An Y; Yang J; Su Z; Sun S; Dai F; Chen Q; Lu Q; Li P; Ling Y; Yang Z; Tang H; Shi L; Jin L; Holmes EC; Ding C; Zhu TY; Zhang YZ
    EMBO J; 2020 Dec; 39(24):e105896. PubMed ID: 33140861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19.
    López-Hernández Y; Monárrez-Espino J; Oostdam AH; Delgado JEC; Zhang L; Zheng J; Valdez JJO; Mandal R; González FLO; Moreno JCB; Trejo-Medinilla FM; López JA; Moreno JAE; Wishart DS
    Sci Rep; 2021 Jul; 11(1):14732. PubMed ID: 34282210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.
    Roberts I; Wright Muelas M; Taylor JM; Davison AS; Xu Y; Grixti JM; Gotts N; Sorokin A; Goodacre R; Kell DB
    Metabolomics; 2021 Dec; 18(1):6. PubMed ID: 34928464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
    Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients.
    Doğan HO; Şenol O; Bolat S; Yıldız ŞN; Büyüktuna SA; Sarıismailoğlu R; Doğan K; Hasbek M; Hekim SN
    J Med Virol; 2021 Apr; 93(4):2340-2349. PubMed ID: 33300133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients.
    Bourgin M; Derosa L; Silva CAC; Goubet AG; Dubuisson A; Danlos FX; Grajeda-Iglesias C; Cerbone L; Geraud A; Laparra A; Aprahamian F; Nirmalathasan N; Madeo F; Zitvogel L; Kroemer G; Durand S
    Aging (Albany NY); 2021 Sep; 13(17):20860-20885. PubMed ID: 34517343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients.
    Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.
    Albóniga OE; Jiménez D; Sánchez-Conde M; Vizcarra P; Ron R; Herrera S; Martínez-Sanz J; Moreno E; Moreno S; Barbas C; Serrano-Villar S
    J Proteome Res; 2022 Mar; 21(3):623-634. PubMed ID: 35133846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
    Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
    J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing plasma and skin imprint metabolic profiles in COVID-19 diagnosis and severity assessment.
    Delafiori J; Siciliano RF; de Oliveira AN; Nicolau JC; Sales GM; Dalçóquio TF; Busanello ENB; Eguti A; de Oliveira DN; Bertolin AJ; Dos Santos LA; Salsoso R; Marcondes-Braga FG; Durán N; Júnior MWP; Sabino EC; Reis LO; Fávaro WJ; Catharino RR
    J Mol Med (Berl); 2024 Feb; 102(2):183-195. PubMed ID: 38010437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.